Scientists found a new Alzheimer’s trigger and a drug that stops it
Scientists have identified a new contributor to Alzheimer's disease, a protein called GRK2, and developed an experimental compound that prevents it from forming harmful clusters in brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer's-related changes, and extended lifespan. The discovery suggests a new approach to treating the disease by targeting a previously unaddressed biological process. The compound, tested over nearly two decades, shows potential for future therapies by breaking a damaging cycle linked to the progression of Alzheimer's.
Scientists discovered a new cause of Alzheimer’s linked to a protein called GRK2 and developed a drug that stops its harmful effects in mice.
This finding could lead to new treatments for Alzheimer’s by targeting a previously unknown process that damages brain cells.
It offers hope for more effective therapies and highlights the power of long-term scientific research to address complex diseases.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.